In Vivo and In Vitro Characterization of Domain Antibodies (dAbs) Targeting CD40 Ligand (CD40L)

被引：0
|
作者：
Suri, A. [1 ]
Tamura, J. [2 ]
Xie, J. [1 ]
Price, L. [3 ]
Ignatovitch, O. [4 ]
Drew, P. [4 ]
Grant, S. [4 ]
Suchard, S. [1 ]
Heifets, M. [5 ]
Nadler, S. [1 ]
机构：
[1] Bristol Myers Squibb, Discovery Immunol, Princeton, NJ USA
[2] Bristol Myers Squibb, Prot Struct & Sci, Princeton, NJ USA
[3] Bristol Myers Squibb, Discovery Biol, Hopewell, VA USA
[4] GSK, Domantis, Cambridge, England
[5] Bristol Myers Squibb, Global Dev Med Affairs, Princeton, NJ USA
来源：
TRANSPLANTATION | 2012年 / 94卷 / 10期
关键词：
D O I：
10.1097/00007890-201211271-00204
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
1244
引用
收藏
页码：111 / 111
页数：1
相关论文
共 50 条
  • [1] In Vivo and In Vitro Characterization of Domain Antibodies (dAbs) Targeting CD40 Ligand (CD40L)
    Xie, J.
    Borowski, V.
    Susulic, V.
    Wang, X.
    Rex-Rabe, S.
    Kuhn, R.
    Carroll, K.
    Brosius, R.
    Ignatovich, O.
    Drew, P.
    Grant, S.
    Tamura, J.
    Bryson, J.
    Salter-Cid, L.
    Suchard, S.
    Nadler, S.
    Suri, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 532 - 532
  • [2] Molecular identity of platelet CD40 ligand (CD40L)
    Weber, AA
    Hermann, A
    Rauch, BH
    Schrör, K
    THROMBOSIS AND HAEMOSTASIS, 2001, 86 (02) : 718 - 718
  • [3] CD40 ligand (CD40L): Biology and clinical use.
    Ghalie, R
    Caron, D
    Fanslow, W
    Armitage, R
    Thomas, E
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S9 - S9
  • [4] The CD40/CD40 ligand (CD40L) pathway plays a role in primary hemostasis and platelet function
    Langer, F
    Ingersoll, SB
    Amirkhosravi, A
    Meyer, TV
    Siddiqui, FA
    Rocca, S
    Ahmad, S
    Walker, JM
    Amaya, M
    Desai, H
    Francis, JL
    BLOOD, 2004, 104 (11) : 436A - 436A
  • [5] CD40与CD40L研究
    张庶民
    中国生物制品学杂志, 2003, (01) : 63 - 64
  • [6] Evidence for a role of the CD40/CD40 ligand (CD40L) pathway in primary hemostasis and platelet function
    Langer, F
    Amirkhosravi, A
    Meyer, TV
    Ingersoll, SB
    Rocca, S
    Siddiqi, FA
    Ahmad, S
    Walker, JM
    Amaya, M
    Francis, JL
    CIRCULATION, 2004, 110 (17) : 328 - 329
  • [7] In vitro and in vivo evidence for a role of the CD40/CD40L system in chronic heart failure
    Varo, N
    Natal, C
    López, N
    López, B
    González, A
    Beloqui, O
    Larman, M
    Querejeta, R
    Diez, J
    Fortuño, MA
    HYPERTENSION, 2005, 46 (04) : 908 - 908
  • [8] Glucocorticoids upregulate CD40 ligand (CD40L) expression and induce CD40L dependent immunoglobulin isotype switching
    Jabara, HH
    Brodeur, SR
    Geha, RS
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (02) : S296 - S296
  • [9] In situ characterization of CD40l and CD40 expression in glomerulonephritis (GN).
    Yellin, MJ
    DAgati, V
    Szabolcs, M
    Parkinson, G
    Han, A
    Baum, D
    Szema, A
    Chess, L
    FASEB JOURNAL, 1996, 10 (06): : 1769 - 1769
  • [10] Regulation of CD40 ligand (CD40L) expression in rheumatoid synovium.
    Kirou, K
    Crow, MK
    FASEB JOURNAL, 2001, 15 (04): : A361 - A361
12345